[Answered] The chief beneficiaries of shock therapy in Russia, at least in the short term, were a. employees ...

This topic contains a solution. Click here to go to the answer

Author Question: The chief beneficiaries of shock therapy in Russia, at least in the short term, were a. employees ... (Read 30 times)

mia

Hero Member
Posts: 564

on: Sep 12, 2019

Question 1

The original occupation of Ignatius Loyola, founder of the Jesuit order, was

a. soldier.
b. professor.
c. priest.
d. lawyer.
e. merchant.

Question 2

The chief beneficiaries of shock therapy in Russia, at least in the short term, were

a. employees of privatized firms.
b. pensioners.
c. former Soviet managers.
d. foreign investors.
e. workers.

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

mceravolo

Sr. Member
Posts: 349

Reply #1 on: Sep 12, 2019

Answer 1

Answer 2

mia

Member
Posts: 564

Reply 2 on: Sep 12, 2019

TYSM

fatboyy09

Member
Posts: 358

Reply 3 on: Yesterday

YES! Correct, THANKS for helping me on my review

« previous next »

Did you know?

The Babylonians wrote numbers in a system that used 60 as the base value rather than the number 10. They did not have a symbol for "zero."

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.